chr6-32038491-G-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_000500.9(CYP21A2):c.69G>T(p.Trp23Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000509 in 1,591,562 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00046 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00051 ( 1 hom. )
Consequence
CYP21A2
NM_000500.9 missense
NM_000500.9 missense
Scores
6
11
Clinical Significance
Conservation
PhyloP100: 1.91
Genes affected
CYP21A2 (HGNC:2600): (cytochrome P450 family 21 subfamily A member 2) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.04066196).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CYP21A2 | NM_000500.9 | c.69G>T | p.Trp23Cys | missense_variant | 1/10 | ENST00000644719.2 | |
CYP21A2 | NM_001128590.4 | c.69G>T | p.Trp23Cys | missense_variant | 1/9 | ||
CYP21A2 | NM_001368143.2 | c.-356G>T | 5_prime_UTR_variant | 1/10 | |||
CYP21A2 | NM_001368144.2 | c.-266G>T | 5_prime_UTR_variant | 1/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CYP21A2 | ENST00000644719.2 | c.69G>T | p.Trp23Cys | missense_variant | 1/10 | NM_000500.9 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000460 AC: 70AN: 152094Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
70
AN:
152094
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000546 AC: 115AN: 210526Hom.: 1 AF XY: 0.000584 AC XY: 67AN XY: 114778
GnomAD3 exomes
AF:
AC:
115
AN:
210526
Hom.:
AF XY:
AC XY:
67
AN XY:
114778
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000514 AC: 740AN: 1439350Hom.: 1 Cov.: 104 AF XY: 0.000522 AC XY: 373AN XY: 714210
GnomAD4 exome
AF:
AC:
740
AN:
1439350
Hom.:
Cov.:
104
AF XY:
AC XY:
373
AN XY:
714210
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000460 AC: 70AN: 152212Hom.: 1 Cov.: 33 AF XY: 0.000403 AC XY: 30AN XY: 74412
GnomAD4 genome
AF:
AC:
70
AN:
152212
Hom.:
Cov.:
33
AF XY:
AC XY:
30
AN XY:
74412
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
43
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Apr 19, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Benign
DEOGEN2
Benign
.;.;.;T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
.;.;D;D;.;.
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
N;N
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;.;D;D;D;.
REVEL
Uncertain
Sift
Uncertain
D;.;D;D;D;.
Sift4G
Benign
T;.;D;D;T;.
Polyphen
D;D;.;.;.;D
Vest4
MutPred
Gain of catalytic residue at W23 (P = 0.026);Gain of catalytic residue at W23 (P = 0.026);Gain of catalytic residue at W23 (P = 0.026);Gain of catalytic residue at W23 (P = 0.026);Gain of catalytic residue at W23 (P = 0.026);Gain of catalytic residue at W23 (P = 0.026);
MVP
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at